This announcement is a separate document:
奥赛康：信息披露管理制度（2024年）
Beijing Aosaikang Pharmaceutical: Information Disclosure Management System (2024)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
10:58
The State Administration for Market Regulation: Focus on rectifying the phenomenon of disrupting fair competition using platform rules and infringing on the legitimate rights and interests of merchants and consumers on the platform, while cracking down on
10:55
The State Administration for Market Regulation: Accelerate the improvement of regulatory systems for platform rules, live commerce, and other aspects.
10:49
The State Administration for Market Regulation: Speed up the development of key standards for 2025, supporting greater effectiveness in the "two new" initiatives.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.